Evidence map›Paper›PMID 34168871›Full record

ArticleAnnals of medicine and surgery (2012)2021

Ossifying fibromyxoid tumor of soft tissue: A case report with review of literature.

Ahlem Bchir, Ahlem Bellalah, Nouha Ben Abdeljelil, Manel Njima, Leila Njim, Abdelfateh Zakhama, Rym Hadhri

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ahlem BchirPathology Department of Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Ahlem BellalahPathology Department of Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Nouha Ben AbdeljelilPathology Department of Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Manel NjimaPathology Department of Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Leila NjimPathology Department of Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Abdelfateh ZakhamaPathology Department of Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Rym HadhriPathology Department of Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Hospital Fatuma Bourguiba Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and importanceThe ossifying fibromyxoid tumor of soft tissue is a rare tumor of intermediate differentiation and uncertain lineage that occurs in adults mostly in the extremities and the trunk. PRESENTATION OF CASE: we present a case of 57 year-old man presenting with a right scapular mass. It was a subcutaneous and painless mass that was largely excised. The diagnosis of ossifying fibromyxoid tumor of the right shoulder was made. The follow up of 1 year was without recurrence and metastasis. CLINICAL DISCUSSION: The ossifying fibromyxoid tumor of soft tissue is exceptional, microscopic diagnosis and management is challenging, considering the scarcity of the tumor.

conclusionMore cases and retrospective studies are needed to understand the pathogenesis and to determine optimal treatment regimens.

Indexed as

Case reportEMA, Epithelial Membrane AntigenEMNST, epithelioid malignant nerve sheath tumorsGFAP, Glial fibrillary acidic proteinIntermediate differentiationOFT, ossifying fibromyxoid tumorOssifying fibromyxoid tumorPathologySEF, sclerosing epithelioid fibrosarcomaSMA, Smooth Muscle ActinSoft tissue

Identifiers

PMID34168871
PMCPMC8209675
OpenAlexW3170513344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.